PF-Atlas › Clinical Trials › NCT01761201
"Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients".
Levofloxacin · Phase 3
Registry ID
NCT01761201
Phase
Phase 3
Status
Terminated
Drug / intervention
Levofloxacin
Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Start
2012-01
Enrollment
68
Locations
18
About this trial
A multicenter, prospective, non-inferiority, randomized and open clinical trial comparing levofloxacin with isoniazid in the treatment of latent tuberculosis infection in patients eligible for liver transplantation. Patients over 18 years of age on the waiting list for liver transplantation. Sample size: n=870 patients. HYPOTHESIS Levofloxacin treatment of latent tuberculosis infection, begun while on the waiting list for liver transplantation, is safer and not less effective than isoniazid treatment begun after transplantation when liver function is stable.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT01761201 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.